PERKINELMER’S ACULED SELECTED BY VISOPIA TO DRIVE BOLD,NEW LIGHTING DESIGN FOR SCION FUSE CONCEPT CAR
Setting the Mood in Illumination with ACULED’s Superior Brightness,Excellent Color Mixing and Compact Size
Fremont, Calif, May 3, 2006 — PerkinElmer Optoelectronics, a global technology leader in digital imaging, specialty lighting and optical detection technologies, today announced that Visopia, a Los Angeles-based advanced lighting design company, selected PerkinElmer’s RGB LED (light emitting diode) design, ACULED (All Color Ultrabright LED), as part of a high power lighting system, for the Scion FUSE 2006 concept car. Visopia leveraged ACULED’s multi chip-on-board (COB) design to create a multi-element headlamp, including high beams, low beams, fog lamps and an innovative color-changing decorative surround in this concept.
Visopia’s ACULED design-in for the Scion FUSE 2006 concept car was previewed at the 2006 New York International Auto Show (NYIAS) held April 14-23, 2006 at The Jacob K. Javits Convention Center in New York City.
“PerkinElmer’s ACULED is a distinctive product that combines the power, color and size qualities we needed to create the concept car’s distinctive signature circuit board design reflecting Scion’s key philosophies of style, versatility and surprise,” said Carlo Quiñonez, lighting designer for Visopia. “The ACULED’s precise white point selection and an infinite palette of color lighting have enabled us to create the perfect balance of ambience and functional lighting.”
“The ACULED’s compact size contributes to our greater design freedom, allowing for integration of lighting functions into the overall front-end design. We believe that the innovative features and performance benefits of the ACULED will ultimately differentiate Scion’s new FUSE model from other vehicles,” Ronny Bagdadi, another partner at Visopia added.
“We are extremely pleased that designers such as Visopia continue to select PerkinElmer’s ACULED solution to help deliver high profile, new product introductions,” said David Nislick, Vice President, PerkinElmer Optoelectronics.
PerkinElmer Optoelectronics is a global technology leader in digital imaging, specialty lighting and optical detection technologies. We provide applications-driven, integrated solutions to leading OEMs in Health Sciences and Industrial Science markets. More information about PerkinElmer Optoelectronics recent announcements is available at http://optoelectronics.perkinelmer.com/content/corporate/news/pressreleases.aspx.
Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging. Photonics markets include sensors and specialty lighting.
PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.5 billion in 2005, has 8,000 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.Where to Buy